Home

Brett R. Hagen, Chief Accounting Officer: Kalaris Therapeutics KLRS Sell · Filed 24/01/25

Trade details

Type
Insider sale
Amount
$603.67
Shares · price
901 sh · $0.67 a share
Held after
96,289 sh
Trade date
24/01/23
Filed
24/01/25
Days to filing
2 days

Sold 0.9% of holdings

Share of holding sold
0.9%

Kalaris Therapeutics trades, last 26 weeks

What else happened in Kalaris Therapeutics around then

Filed or reported within 30 days of the trade day · 23/12/24~24/02/22

Brett R. Hagen's recent trades

  • Brett R. Hagen

    SellKalaris Therapeutics

    $12.9K

    Filed 03/23

  • Brett R. Hagen

    Planned saleKalaris Therapeutics

    $12.9K

    Filed 03/20

  • Brett R. Hagen

    SellKalaris Therapeutics

    $8,136

    Filed 25/03/27

  • Brett R. Hagen

    SellKalaris Therapeutics

    $968

    Filed 25/02/24

  • Brett R. Hagen

    Planned saleKalaris Therapeutics

    $967

    Filed 25/02/24

Brett R. Hagen, CAO — sold $604 of Kalaris Therapeutics KLRS · 0.9% of holdings | Whalegun